20 Mar 2019 A North Carolina federal jury determined Puma acted with actual malice by falsely stating in an investor presentation that Eshelman had been 7 Jun 2017 Additionally, the investor presentation stated that "Puma's Board does not believe that someone who was involved in clinical trial fraud that was 10 Aug 2018 Puma Biotechnology jumped as much as 11% Friday after its reversed course amid analyst doubt for future sales of breast cancer drug Nerlynx. X "Notably, management no longer presented the breakdown of new patient 15 Feb 2019 The jury found that Puma and Auerbach knowingly misled investors about results of the clinical trial were presented at a medical conference.
Get breaking news and analysis on Puma Biotechnology, Inc. (PBYI) stock, price quote and chart, trading and investing tools. The Value Investor Earnings Call Presentation. Get the latest price and volume on Puma Biotechnology Inc in IBD stock charts. Our investment research resources are provided to help you make informed investment decisions. PBYI, Puma Biotechnology Inc - Stock Investment Research, IBD Stock Charts - Investors.com
Beginning on January 13, 2020, representatives of Puma Biotechnology, Inc. (the “Company”) intend to make presentations at investor conferences and in other forums, and these presentations may include the information contained in Exhibit 99.1 attached to this Current Report on Form 8-K. A copy of LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE:PBYI), a development stage biopharmaceutical company, announced the presentation of positive results from an ongoing Phase II clinical trial of Puma's investigational drug PB272 (neratinib) for the treatment of HER2 positive metastatic breast cancer that has metastasized to the brain. Puma Biotechnology to Present at Cowen’s Annual Health Care Conference Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 9:20 a.m. EST on Wednesday, March 4 at the Cowen and Company Get breaking news and analysis on Puma Biotechnology, Inc. (PBYI) stock, price quote and chart, trading and investing tools. The Value Investor Earnings Call Presentation. Get the latest price and volume on Puma Biotechnology Inc in IBD stock charts. Our investment research resources are provided to help you make informed investment decisions. PBYI, Puma Biotechnology Inc - Stock Investment Research, IBD Stock Charts - Investors.com
25 Jan 2013 In December 2018, Puma presented updated interim SUMMIT results at the 2018 San On behalf of Puma Biotechnology, I would like to thank our We cannot predict the extent to which investor interest in our company will
On Jan. 13, 2020, Puma Biotechnology released the slides that CEO Alan Auerbach will present at the J.P. Morgan Healthcare Conf. on Jan. 15.